Nutritional Approaches to Modulate Cardiovascular Disease Risk in Systemic Lupus Erythematosus: A Literature Review

Karen Pesqueda-Cendejas1,2,3, Melissa Rivera-Escoto1,2,4, Mónica R Meza-Meza1,2,4

  • 1Red de Inmunonutrición y Genómica Nutricional en las Enfermedades Autoinmunes, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.

Nutrients
|February 25, 2023
PubMed

Insights

Nutritional strategies may mitigate cardiovascular disease (CVD) risk in systemic lupus erythematosus (SLE) patients. This review explores how nutrients can address traditional and non-traditional CVD risk factors, potentially improving SLE prognosis.

Area of Science:

  • Rheumatology
  • Cardiology
  • Nutrition Science

Background:

  • Systemic lupus erythematosus (SLE) presents a bimodal mortality pattern, with cardiovascular disease (CVD) being a significant contributor.
  • SLE patients face elevated CVD risk due to traditional factors (obesity, dyslipidemia, hypertension) and non-traditional factors (inflammation, hyperhomocysteinemia).

Purpose of the Study:

  • To critically review the therapeutic potential of nutritional approaches in managing CVD risk factors in SLE patients.
  • To explore how specific nutrients may modulate immunomodulatory, antioxidant, and anti-cardiometabolic risk properties relevant to SLE comorbidities.

Main Methods:

  • Critical literature review of existing research on SLE, CVD risk factors, and nutritional interventions.
  • Analysis of studies investigating the impact of nutrients on traditional and non-traditional CVD risk factors in the context of SLE.

Main Results:

  • Several nutrients possess properties that could reduce SLE severity and organ damage.
  • Nutritional interventions may help decrease the development of both traditional and non-traditional CVD risk factors in SLE.

Conclusions:

  • Nutritional approaches offer therapeutic potential for managing CVD comorbidities in SLE.
  • Modulating nutritional status could be a key strategy to improve the long-term prognosis of SLE patients by reducing cardiovascular risk.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
42
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
24
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
26
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
28
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
31